STOCK TITAN

Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology Week

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) has announced its participation in the Jefferies Virtual Synthetic Biology Week, scheduled for March 22, 2022, at 10:00 a.m. Eastern Time. Management will engage in a fireside chat during this event. Details, including a webcast link and a replay, will be available on the company's investor relations website. Ginkgo operates a platform for cell programming, supporting various biotechnology applications across markets like food, agriculture, and pharmaceuticals, while also contributing to COVID-19 response efforts.

Positive
  • Participation in Jefferies Virtual Synthetic Biology Week demonstrates Ginkgo's engagement in the synthetic biology sector.
  • Platform enables diverse biotechnology applications across multiple markets, suggesting versatile revenue potential.
Negative
  • None.

BOSTON, March 15, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in a fireside chat at Jefferies Virtual Synthetic Biology Week, on March 22, 2022, at 10:00 a.m. Eastern Time.

Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at https://investors.ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.

Ginkgo Bioworks Contacts: 
INVESTOR CONTACT: 
investors@ginkgobioworks.com 

MEDIA CONTACT: 
press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-jefferies-virtual-synthetic-biology-week-301502443.html

SOURCE Ginkgo Bioworks

FAQ

What event is Ginkgo Bioworks participating in?

Ginkgo Bioworks is participating in the Jefferies Virtual Synthetic Biology Week on March 22, 2022.

When is Ginkgo Bioworks' fireside chat scheduled?

The fireside chat is scheduled for March 22, 2022, at 10:00 a.m. Eastern Time.

What is Ginkgo Bioworks' ticker symbol?

Ginkgo Bioworks' ticker symbol is DNA.

Where can I find more information about Ginkgo Bioworks' fireside chat?

Further details and a webcast link will be posted on Ginkgo Bioworks' investor relations website.

What does Ginkgo Bioworks focus on?

Ginkgo Bioworks focuses on programming cells for various biotechnology applications in markets like food, agriculture, and pharmaceuticals.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

368.44M
42.27M
6.15%
68.55%
13.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON